<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0070">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Lipton</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fizazi</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Stopeck</surname>
    <given-names>AT</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group> (
  <year>2016</year>). 
  <article-title>Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics</article-title>. 
  <source>Eur J Cancer</source>
  <volume>53</volume>:
  <fpage>75</fpage>–
  <lpage>83</lpage>.
  <pub-id pub-id-type="pmid">26693901</pub-id>
 </mixed-citation>
</ref>
